Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Cardiologist dies from COVID-19 | Type 2 diabetes associated with a high risk of heart attack or stroke
Monday, November 23, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Top Stories

Revered cardiologist dies from COVID-19

A moment of silence has been planned to celebrate the late cardiologist's memory. 

READ MORE >
Gershlick
Share on Twitter Share on Facebook Share on Linkedin

Revered cardiologist dies from COVID-19

Share on Twitter Share on Facebook Share on Linkedin
Gershlick
A moment of silence has been planned to celebrate the late cardiologist's memory. 
READ MORE >

93% of patients with type 2 diabetes are at an increased risk of a fatal heart attack or stroke

The study, published in the European Journal of Preventive Cardiology, included data from nearly 374,000 adult patients. 

READ MORE >
Head CT in the ED
Share on Twitter Share on Facebook Share on Linkedin

93% of patients with type 2 diabetes are at an increased risk of a fatal heart attack or stroke

Share on Twitter Share on Facebook Share on Linkedin
Head CT in the ED
The study, published in the European Journal of Preventive Cardiology, included data from nearly 374,000 adult patients. 
READ MORE >

American Heart Association, American College of Cardiology share updated guidance on hypertrophic cardiomyopathy

The two groups emphasized the importance of shared decision-making and detailed when patients can consider competitive sports. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association, American College of Cardiology share updated guidance on hypertrophic cardiomyopathy

Share on Twitter Share on Facebook Share on Linkedin
The two groups emphasized the importance of shared decision-making and detailed when patients can consider competitive sports. 
READ MORE >

Featured Articles

Ablation outperforms drug therapy as an initial treatment for atrial fibrillation

Drug therapy is typically recommended for the initial treatment of patients with atrial fibrillation, but new research suggests there could be a more effective way. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Ablation outperforms drug therapy as an initial treatment for atrial fibrillation

Share on Twitter Share on Facebook Share on Linkedin
Drug therapy is typically recommended for the initial treatment of patients with atrial fibrillation, but new research suggests there could be a more effective way. 
READ MORE >

Empagliflozin improves outcomes for non-diabetic HFrEF patients

Treatment with empagliflozin for six months was associated with several key improvements. This suggests that, yes, SGLT2 inhibitors can be recommended for HFrEF patients who don't have diabetes. 

READ MORE >
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.
Share on Twitter Share on Facebook Share on Linkedin

Empagliflozin improves outcomes for non-diabetic HFrEF patients

Share on Twitter Share on Facebook Share on Linkedin
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.
Treatment with empagliflozin for six months was associated with several key improvements. This suggests that, yes, SGLT2 inhibitors can be recommended for HFrEF patients who don't have diabetes. 
READ MORE >

COVID-related social isolation associated with high blood pressure

During a government-regulated lockdown in Argentina, patients admitted to the emergency department were much more likely to have high blood pressure. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

COVID-related social isolation associated with high blood pressure

Share on Twitter Share on Facebook Share on Linkedin
During a government-regulated lockdown in Argentina, patients admitted to the emergency department were much more likely to have high blood pressure. 
READ MORE >

Fauci discusses the ongoing pandemic, social distancing, when a COVID-19 vaccine may be available and much more

Anthony S. Fauci, MD, a central figure in the White House Coronavirus Task Force, spoke at length about COVID-19 during the AHA's Scientific Sessions 2020 virtual meeting. 

READ MORE >
Fauci virtual meeting screen grab
Share on Twitter Share on Facebook Share on Linkedin

Fauci discusses the ongoing pandemic, social distancing, when a COVID-19 vaccine may be available and much more

Share on Twitter Share on Facebook Share on Linkedin
Fauci virtual meeting screen grab
Anthony S. Fauci, MD, a central figure in the White House Coronavirus Task Force, spoke at length about COVID-19 during the AHA's Scientific Sessions 2020 virtual meeting. 
READ MORE >

From the Magazine

When Fear Goes Viral - What to Say to a Frightened Patient

SCAI’s president explains the key points she shares when reassuring patients who are reluctant to present for care.

READ MORE >
When Fear goes Viral
Share on Twitter Share on Facebook Share on Linkedin

When Fear Goes Viral - What to Say to a Frightened Patient

Share on Twitter Share on Facebook Share on Linkedin
When Fear goes Viral
SCAI’s president explains the key points she shares when reassuring patients who are reluctant to present for care.
READ MORE >

In Other News

Stanford addresses controversial radiologist Scott Atlas’ ‘rise up’ comments, while others demand his firing

The Hoover Institution fellow and White House COVID-19 advisor drew fire earlier this week for urging Michigan residents to stand up against further lockdowns. 

READ MORE >
Stanford University
Share on Twitter Share on Facebook Share on Linkedin

Stanford addresses controversial radiologist Scott Atlas’ ‘rise up’ comments, while others demand his firing

Share on Twitter Share on Facebook Share on Linkedin
Stanford University
The Hoover Institution fellow and White House COVID-19 advisor drew fire earlier this week for urging Michigan residents to stand up against further lockdowns. 
READ MORE >

5 mixed takes on the opening of Amazon Pharmacy

When Amazon opened the doors of its drugstore business Nov. 17, the potential competitive ramifications rattled that industry on many levels. Would establishment drug sellers stand a chance against the mighty retail innovator?

READ MORE >
Amazon truck
Share on Twitter Share on Facebook Share on Linkedin

5 mixed takes on the opening of Amazon Pharmacy

Share on Twitter Share on Facebook Share on Linkedin
Amazon truck
When Amazon opened the doors of its drugstore business Nov. 17, the potential competitive ramifications rattled that industry on many levels. Would establishment drug sellers stand a chance against the mighty retail innovator?
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme